Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind trial of tazarotene + clindamycin phosphate cream for acne vulgaris
CTR20210119Phase 2Completed
- Sponsor
- Ziyond Pharmaceutical
- Start
- Mar 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tazarotene, clindamycin in acne vulgaris, sponsored by Ziyond Pharmaceutical. Started Mar 2021; status: completed.
02
Drugs
tazaroteneclindamycin
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on CTR20210119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210119.